Invention Grant
- Patent Title: Immunoregulatory agents
-
Application No.: US16123912Application Date: 2018-09-06
-
Publication No.: US10533014B2Publication Date: 2020-01-14
- Inventor: Hilary Plake Beck , Juan Carlos Jaen , Maksim Osipov , Jay Patrick Powers , Maureen Kay Reilly , Hunter Paul Shunatona , James Ross Walker , Mikhail Zibinsky , James Aaron Balog , David K. Williams , Jay A. Markwalder , Emily Charlotte Cherney , Weifang Shan , Audris Huang
- Applicant: Flexus Biosciences, Inc.
- Applicant Address: US NJ Princeton
- Assignee: FLEXUS BIOSCIENCES, INC.
- Current Assignee: FLEXUS BIOSCIENCES, INC.
- Current Assignee Address: US NJ Princeton
- Agency: BakerHostetler
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/47 ; C07D215/06 ; C07D231/56 ; A61K31/416 ; C07D215/233 ; C07D471/04 ; A61K31/437 ; C07D239/74 ; A61K31/517 ; A61K31/4375 ; C07D217/04 ; C07D405/08 ; A61K31/4709 ; C07D417/08 ; C07D401/12 ; C07D401/14 ; A61K31/506 ; A61K31/496 ; A61K31/519 ; A61K45/06 ; C07D215/14 ; C07D405/12 ; C07D417/12 ; A61P35/02 ; C07D215/12 ; C07D217/12 ; C07D217/24 ; A61K39/395
Abstract:
Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.
Public/Granted literature
- US20190002472A1 IMMUNOREGULATORY AGENTS Public/Granted day:2019-01-03
Information query
